Findings were published from the first study by a drug company to examine ketamine as a treatment option for depression. The study, conducted by Janssen Research and Development and the Yale School of Medicine, was published in the American Journal of Psychiatry (AJP) on April 16. It was funded by Janssen Research and Development, LLC. Ketamine…